93 related articles for article (PubMed ID: 4794920)
1. Effect of therapy and tumour stage on cellular immunity to bladder carcinoma.
O'Toole CM
Adv Exp Med Biol; 1973; 29(0):477-82. PubMed ID: 4794920
[No Abstract] [Full Text] [Related]
2. The cellular immune response to carcinoma of the urinary bladder: correlation to clinical stage and treatment.
O'Toole C; Unsgaard B; Almgård LE; Johansson B
Br J Cancer Suppl; 1973 Aug; 1():266-75. PubMed ID: 4804285
[TBL] [Abstract][Full Text] [Related]
3. Lymphocyte-mediated tumor cell destruction in vitro. Some general principles and reactivities in human urinary bladder carcinoma.
Perlmann P; O'Toole C; Unsgaard B
Natl Cancer Inst Monogr; 1972 Dec; 35():223-9. PubMed ID: 4540587
[No Abstract] [Full Text] [Related]
4. Cellular immunity to human urinary bladder carcinoma. II. EEffect of surgery and preoperative irradiation.
O'Toole C; Perlmann P; Unsgaard B; Almgård LE; Johansson B; Moberger G; Edsmyr F
Int J Cancer; 1972 Jul; 10(1):92-8. PubMed ID: 4196437
[No Abstract] [Full Text] [Related]
5. Cellular cytotoxicity in vitro in transitional cell carcinoma of the human urinary bladder: 51Cr-release assay.
Troye M; Perlmann P; Larsson A; Blomgren H; Johansson B
Int J Cancer; 1977 Aug; 20(2):188-98. PubMed ID: 892930
[No Abstract] [Full Text] [Related]
6. Cell-mediated cytotoxicity for bladder carcinoma: evaluation of a workshop.
Bean MA; Bloom BR; Herberman RB; Old LJ; Oettgen HF; Klein G; Terry WD
Cancer Res; 1975 Oct; 35(10):2902-13. PubMed ID: 1157057
[No Abstract] [Full Text] [Related]
7. Cellular immunity to human urinary bladder carcinoma. I. Correlation to clinical stage and radiotherapy.
O'Toole C; Perlmann P; Unsgaard B; Moberger G; Edsmyr F
Int J Cancer; 1972 Jul; 10(1):77-91. PubMed ID: 4196436
[No Abstract] [Full Text] [Related]
8. Standardization of microcytotoxicity assay for cell-mediated immunity.
O'Toole C
Natl Cancer Inst Monogr; 1973 Jun; 37():19-24. PubMed ID: 4713781
[No Abstract] [Full Text] [Related]
9. Cellular cytotoxicity in transitional cell carcinoma of the human urinary bladder - a summary.
Perlmann P; Troye M; Pape G; Blomgren H; Johansson B
Urol Res; 1978; 6(4):207-9. PubMed ID: 741533
[TBL] [Abstract][Full Text] [Related]
10. Characterization of cytolytic effector cells in peripheral blood of healthy individuals and cancer patients. II. Cytotoxicity to allogeneic or autochthonous tumor cells in tissue culture.
Pape GR; Troye M; Perlmann P
J Immunol; 1977 Jun; 118(6):1925-30. PubMed ID: 325130
[No Abstract] [Full Text] [Related]
11. A 51chromium isotope release assay for detecting cytotoxicity to human bladder carcinoma.
O'Toole C
Int J Cancer; 1977 Mar; 19(3):324-31. PubMed ID: 844912
[TBL] [Abstract][Full Text] [Related]
12. Murine bladder tumors as models for human tumor immunity.
Hellström I; Hellström KE
Natl Cancer Inst Monogr; 1972 Dec; 35():125-7. PubMed ID: 4659043
[No Abstract] [Full Text] [Related]
13. Tumor-associated and spontaneous lymphocyte-mediated cytotoxicity against cell lines derived from human urothelium.
Vilien M
Dan Med Bull; 1985 Aug; 32(4):199-218. PubMed ID: 3899526
[No Abstract] [Full Text] [Related]
14. Cell-mediated immune mechanisms of tumor cell destruction.
Perlmann P; O'Toole C; Unsgaard B
Fed Proc; 1973 Feb; 32(2):153-5. PubMed ID: 4540104
[No Abstract] [Full Text] [Related]
15. Lymphoid cells mediating tumor-specific cytotoxicity to carcinoma of the urinary bladder. Separation of the effector population using a surface marker.
O'Toole C; Stejskal V; Perlmann P; Karlsson M
J Exp Med; 1974 Mar; 139(3):457-66. PubMed ID: 4591169
[TBL] [Abstract][Full Text] [Related]
16. Lymphocyte cytotoxicity in bladder cancer. No requirement for thymus-derived effector cells?
O'Toole C; Perlmann P; Wigzell H; Unsgaard B; Zetterlund CG
Lancet; 1973 May; 1(7812):1085-8. PubMed ID: 4123535
[No Abstract] [Full Text] [Related]
17. Some immunological considerations relevant to the study of human bladder cancer.
Bean MA
Cancer Res; 1977 Aug; 37(8 Pt 2):2879-84. PubMed ID: 326394
[TBL] [Abstract][Full Text] [Related]
18. Lymphocyte mediated cytotoxicity to tumor antigens.
Hellström I; Hellström KE
Johns Hopkins Med J Suppl; 1974; 3():37-50. PubMed ID: 4608238
[No Abstract] [Full Text] [Related]
19. The specificity of the microcytotoxicity assay for cell-mediated immunity in human bladder cancer.
Vilien M; Wolf H
J Urol; 1978 Mar; 119(3):338-42. PubMed ID: 273706
[TBL] [Abstract][Full Text] [Related]
20. Specific antibody activation of lymphocytes for cell-mediated cytotoxicity against cultured target cells.
Takasugi M; Kinoshita K
J Natl Cancer Inst; 1974 Dec; 53(6):1539-44. PubMed ID: 4474407
[No Abstract] [Full Text] [Related]
[Next] [New Search]
